USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark OLIGOSURF was filed as Word mark on 08/16/2000 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 12/03/2002.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word mark |
| File reference | 76113579 |
| Register number | 2655564 |
| Application date | August 16, 2000 |
| Publication date | September 10, 2002 |
| Entry date | December 3, 2002 |
Trademark owner
7 Clarke Drive
08512 Cranbury
US
08512 Cranbury
US
Trademark representatives
goods and services
42
Describing and providing services for scientific and medical research services, namely, screening of oligonucleotide libraries to identify active anti-sense oligonucleotides for use in pharmaceutical preparations for administration via various routes, including respiratory airways, for testing and prophylaxis and therapeutic treatment of human and non-human animal ailments that may be associated with hyper-sensitivity or hyper-responsiveness to adenosine, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in many cases are adenosine receptor associated symptoms, particularly testing, preventing and therapeutically treating respiratory, airway, pulmonary and other diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma; impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, ___ bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g. colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, hepatic metastases, etc., as well as all other metastatic cancers, e.g. cancers which metastasized to the lung(s), breast and prostate
ID: 1376113579